NewEdge Advisors’s Amedisys AMED Stock Holding History

NewEdge Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13	Closed	-$1.28K	–	4098
2025 Q2	$1.28K	Hold	13	–	–	﹤0.01%	3692
2025 Q1	$1.2K	Hold	13	–	–	﹤0.01%	3595
2024 Q4	$1.18K	Hold	13	–	–	﹤0.01%	3540
2024 Q3	$1.25K	Hold	13	–	–	﹤0.01%	3471
2024 Q2	$1.19K	Hold	13	–	–	﹤0.01%	3428
2024 Q1	$1.2K	Hold	13	–	–	﹤0.01%	3464
2023 Q4	$1.24K	Buy	+13	New	+$1.21K	﹤0.01%	3430

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

NewEdge Advisors's AMED Position: Q3 2025 in Review

NewEdge Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 13 shares — an estimated $1.28K sold.

NewEdge Advisors first reported a position in AMED in Q4 2023 and held it in 7 quarters. The position peaked at $1.28K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

NewEdge Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
NewEdge Advisors sold 13 Amedisys shares in Q3 2025, an estimated $1.28K.
NewEdge Advisors first reported a position in Amedisys in Q4 2023 and held it in 7 quarters.
NewEdge Advisors's Amedisys position peaked at $1.28K in Q2 2025.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on NewEdge Advisors's 13F filing for Q3 2025, filed 17 Nov 2025.